Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 1388 Neoplasms 1168 Colorectal Neoplasms 626 Lung Neoplasms 562 Prostatic Neoplasms 538 Carcinoma, Non-Small-Cell Lung 444 Carcinoma, Hepatocellular 296 Stomach Neoplasms 272 Pancreatic Neoplasms 270 Colonic Neoplasms 264 Ovarian Neoplasms 231 Head and Neck Neoplasms 228 Rectal Neoplasms 221 Melanoma 216 Multiple Myeloma 204 Uterine Cervical Neoplasms 198 Lymphoma 195 Leukemia 193 Precursor Cell Lymphoblastic Leukemia-Lymphoma 191 Neoplasm Metastasis 178 Carcinoma, Renal Cell 177 Brain Neoplasms 174 Esophageal Neoplasms 173 Leukemia, Myeloid, Acute 158 Urinary Bladder Neoplasms 138 Recurrence 123 Polycystic Ovary Syndrome 122 Liver Neoplasms 119 Hematologic Neoplasms 117 Endometrial Neoplasms 107

Interventions

enzalutamide 1 darolutamide 1 apalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Observational × Non-metastatic Prostate Cancer × Clear all

NCT06204302 2024-04-09

ARENA

Bayer

Non-metastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡